Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma.
Eve, Heather E
Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov 2009 - e189-90; author reply e191 p. digital
Publication Type: Comment; Letter
1527-7755
10.1200/JCO.2009.23.9731 doi
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Humans
Lymphoma, Mantle-Cell--drug therapy
Prednisolone--administration & dosage
Prognosis
Survival Analysis
Time Factors
Treatment Outcome
Vincristine--administration & dosage
Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov 2009 - e189-90; author reply e191 p. digital
Publication Type: Comment; Letter
1527-7755
10.1200/JCO.2009.23.9731 doi
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Humans
Lymphoma, Mantle-Cell--drug therapy
Prednisolone--administration & dosage
Prognosis
Survival Analysis
Time Factors
Treatment Outcome
Vincristine--administration & dosage